Prevalence and Incidence of Osteoarthritis: A Population-Based Retrospective Cohort Study

被引:42
作者
Hamood, Rola [1 ]
Tirosh, Matanya [1 ]
Fallach, Noga [2 ]
Chodick, Gabriel [2 ,3 ]
Eisenberg, Elon [4 ]
Lubovsky, Omri [5 ]
机构
[1] Med Affairs Pfizer Inc, IL-4672509 Herzliyya, Israel
[2] Kahn Sagol Maccabi Res & Innovat Inst, Maccabi Healthcare Serv, IL-6812509 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel
[4] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Rambam Hlth Care Campus, IL-3525433 Haifa, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr Ashkelon Israel, IL-8410501 Beer Sheva, Israel
关键词
osteoarthritis; prevalence; incidence; trends; Middle East; PRACTICE RESEARCH DATALINK; WHO-ILAR COPCORD; KNEE OSTEOARTHRITIS; GLOBAL BURDEN; RISK-FACTORS; EPIDEMIOLOGY; TRENDS; AGE; DISEASE; HIP;
D O I
10.3390/jcm10184282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While trends data of osteoarthritis (OA) are accumulating, primarily from Western Europe and the US, a gap persists in the knowledge of OA epidemiology in Middle Eastern populations. This study aimed to explore the prevalence, incidence, correlations, and temporal trends of OA in Israel during 2013-2018, using a nationally representative primary care database. On 31 December 2018, a total of 180,126 OA patients were identified, representing a point prevalence of 115.3 per 1000 persons (95% CI, 114.8-115.8 per 1000 persons). Geographically, OA prevalence was not uniformly distributed, with the Southern and Northern peripheral districts having a higher prevalence than the rest of the Israeli regions. OA incidence increased over time from 7.36 per 1000 persons (95% CI 6.21-7.50 per 1000 persons) in 2013 to 8.23 per 1000 persons (95% CI 8.09-8.38 per 1000 persons) in 2017 (p-value for trend = 0.02). The incidence was lowest in patients under 60 years (in both sexes) and peaked at 60-70 years. In older ages, the incidence leveled off in men and declined in women. The growing risk of OA warrants a greater attention to timely preventive and therapeutic interventions. Further population-based studies in the Middle East are needed to identify modifiable risk factors for timely preventive and therapeutic interventions.
引用
收藏
页数:11
相关论文
共 35 条
[1]  
Abdel-Tawab R.R., P 11 APLAR C JEJ KOR
[2]  
Al Saleh Jamal, 2016, Oman Med J, V31, P117, DOI 10.5001/omj.2016.23
[3]  
Al-Arfaj AS, 2003, SAUDI MED J, V24, P291
[4]  
Al-Awadhi A, 2002, J RHEUMATOL, V29, P1754
[5]   Why is osteoarthritis an age-related disease? [J].
Anderson, A. Shane ;
Loeser, Richard F. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2010, 24 (01) :15-26
[6]   The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study [J].
Cross, Marita ;
Smith, Emma ;
Hoy, Damian ;
Nolte, Sandra ;
Ackerman, Ilana ;
Fransen, Marlene ;
Bridgett, Lisa ;
Williams, Sean ;
Guillemin, Francis ;
Hill, Catherine L. ;
Laslett, Laura L. ;
Jones, Graeme ;
Cicuttini, Flavia M. ;
Osborne, Richard ;
Vos, Theo ;
Buchbinder, Rachelle ;
Woolf, Anthony ;
March, Lyn .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1323-1330
[7]   Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies [J].
Cui, Aiyong ;
Li, Huizi ;
Wang, Dawei ;
Zhong, Junlong ;
Chen, Yufeng ;
Lu, Huading .
ECLINICALMEDICINE, 2020, 29-30
[8]  
Davatchi F, 2008, J RHEUMATOL, V35, P1384
[9]   The epidemiology of psoriatic arthritis in Israel - a population-based study [J].
Eder, Lihi ;
Cohen, Arnon Dov ;
Feldhamer, Ilan ;
Greenberg-Dotan, Sari ;
Batat, Erez ;
Zisman, Devy .
ARTHRITIS RESEARCH & THERAPY, 2018, 20
[10]   Pain Pharmacotherapy in a Large Cohort of Patients with Osteoarthritis: A Real-World Data Analysis [J].
Fallach, Noga ;
Chodick, Gabriel ;
Tirosh, Matanya ;
Eisenberg, Elon ;
Lubovsky, Omri .
RHEUMATOLOGY AND THERAPY, 2021, 8 (03) :1129-1141